News and views for the UB community
COVID-19 UPDATES • 11/20/2021
David Doermann will serve as director of the institute, which will pursue multidisciplinary research, education and curriculum development.
In her new role, the UB researcher will elevate the delivery of integrated care for children with genetic disorders in WNY and beyond.
Conducted in late 2020, the UB-led study of ciclesonide was one of the first to look at steroids in patients with mild to moderate disease.
A UB-led study found that low income, male gender or living in an urban setting are each tied to a higher risk of hospital readmission.
Researchers found children treated with dexrazoxane have healthier hearts than those who didn’t receive the drug, proving its safety and efficacy.
The findings point to a need for public education to reduce recycling stream contamination, UB researchers say.
At a hearing on opioid use disorder, Robert McCormack told legislators how the MATTERS program is implementing the “warm handoff.”
New research illuminates the properties of protein-RNA droplets.
The findings of a UB study may improve understanding of such chronic inflammatory, bone-related diseases as gum disease, arthritis and osteoporosis.
The researchers' PSA video was particularly effective for those who don't feel confident about recycling.